Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

(NASDAQ:WAVE) Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 ”M total AAT, 7....

What are the projected milestones and timeline for FDA approval and commercialization following this trial result? What does the achieved serum AAT protein level mean relative to existing therapies for Alpha‑1 Antitrypsin deficiency? How will the positive RestorAATion-2 trial update influence WAVE's near‑term share price and trading volume?
Symbol: WAVE
Clinical trials
11 days ago
Read more globenewswire

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

(VACC) VAX-31 Optimized Dose, with Majority of Serotypes Dosed at 4.4mcg and Balance at 3.3mcg, is Designed to Elicit Even Stronger Immune Responses in Infant Population to Protect Against Invasive...

How does VAX‑31's optimized dosing strategy and expected efficacy compare with existing pneumococcal vaccines and pipeline competitors? What is the projected timeline for data readout and potential regulatory milestones, and how does this align with the company's cash runway? How will the Phase 2 dose-finding results affect VACC's short‑term stock valuation and trading volume?
Symbol: VACC
Clinical trials
11 days ago
Read more globenewswire

CME Group Reports Second-Highest August ADV of 28.1 Million Contracts

(NASDAQ:CME) Record monthly ADV in cryptocurrency products CHICAGO, Sept. 3, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its second-highest August av...

Is the increasing volume likely to intensify competition from other exchanges offering crypto products, and how might that impact CME's market share? What does the second‑highest August ADV reveal about the growth trajectory of cryptocurrency derivatives relative to traditional futures markets? How will the record August ADV affect CME's upcoming revenue and earnings guidance?
Symbol: CME
Derivatives
11 days ago
Read more prnewswire

Smithfield Foods Announces Launch of Secondary Offering of Common Stock

(NYSE:SF) Smithfield Foods Announces Launch of Secondary Offering of Common Stock

How does Smithfield Foods plan to use the proceeds from the secondary offering, and what impact will that have on its growth strategy and financial outlook? What is the targeted price range for the secondary offering and how is market demand expected to influence it? Will the secondary offering dilute existing shareholders and affect earnings per share?
Symbol: SF
Secondary offering
11 days ago
Read more globenewswire